APA (7th ed.) Citation

Button, B., Rang, C., Poulsen, M., Wilson, L., Keating, D., Kotsimbos, T., & Wilson, J. (2022). P204 Elexacaftor/tezacaftor/ivacaftor - positive effects on quality of life using the AWESCORE and exercise capacity using the A-STEP in adults with end-stage cystic fibrosis. Journal of Cystic Fibrosis, 21, S123. https://doi.org/10.1016/S1569-1993(22)00533-1

Chicago Style (17th ed.) Citation

Button, B., C. Rang, M. Poulsen, L. Wilson, D. Keating, T. Kotsimbos, and J. Wilson. "P204 Elexacaftor/tezacaftor/ivacaftor - Positive Effects on Quality of Life Using the AWESCORE and Exercise Capacity Using the A-STEP in Adults with End-stage Cystic Fibrosis." Journal of Cystic Fibrosis 21 (2022): S123. https://doi.org/10.1016/S1569-1993(22)00533-1.

MLA (9th ed.) Citation

Button, B., et al. "P204 Elexacaftor/tezacaftor/ivacaftor - Positive Effects on Quality of Life Using the AWESCORE and Exercise Capacity Using the A-STEP in Adults with End-stage Cystic Fibrosis." Journal of Cystic Fibrosis, vol. 21, 2022, p. S123, https://doi.org/10.1016/S1569-1993(22)00533-1.